Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
Huober J, Barrios CH, Niikura N, Jarząb M, Chang YC, Huggins-Puhalla SL, Pedrini J, Zhukova L, Graupner V, Eiger D, Henschel V, Gochitashvili N, Lambertini C, Restuccia E, Zhang H; IMpassion050 Trial Investigators. Huober J, et al. Among authors: jarzab m. J Clin Oncol. 2022 Sep 1;40(25):2946-2956. doi: 10.1200/JCO.21.02772. Epub 2022 Jun 28. J Clin Oncol. 2022. PMID: 35763704 Free PMC article. Clinical Trial.
Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Bolanowski M, Bednarczuk T, Bobek-Billewicz B, Handkiewicz-Junak D, Jeziorski A, Nowakowska-Duława E, Steinhof-Radwańska K, Zajęcki W, Zemczak A, Kos-Kudła B; Consensus Conference; Polish Network of Neuroendocrine Tumours. Bolanowski M, et al. Endokrynol Pol. 2013;64(6):480-93. doi: 10.5603/EP.2013.0029. Endokrynol Pol. 2013. PMID: 24431119 Free article.
Gastroduodenal neuroendocrine neoplasms including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Rydzewska G, Cichocki A, Ćwikła JB, Foltyn W, Hubalewska-Dydejczyk A, Kamiński G, Lewczuk A, Nasierowska-Guttmejer A, Nowakowska-Duława E, Pilch-Kowalczyk J, Sowa-Staszczak A, Kos-Kudła B; Consensus Conference; Polish Network of Neuroendocrine Tumours. Rydzewska G, et al. Endokrynol Pol. 2013;64(6):444-58. doi: 10.5603/EP.2013.0030. Endokrynol Pol. 2013. PMID: 24431117 Free article.
Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
Jarzab M, Kowal M, Bal W, Oczko-Wojciechowska M, Rembak-Szynkiewicz J, Kowalska M, Stobiecka E, Chmielik E, Tyszkiewicz T, Kaszuba M, Nowicka E, Lange B, Czarniecka A, Krajewska J, Dyla A, Dobrut M, Lange D, Jarzab B, Bobek-Billewicz B, Tarnawski R. Jarzab M, et al. Among authors: jarzab b. Folia Histochem Cytobiol. 2016;54(4):202-209. doi: 10.5603/FHC.a2016.0026. Epub 2017 Jan 4. Folia Histochem Cytobiol. 2016. PMID: 28051275 Free article.
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer.
Kubeczko M, Gabryś D, Gawkowska M, Polakiewicz-Gilowska A, Cortez AJ, Krzywon A, Woźniak G, Latusek T, Leśniak A, Świderska K, Mianowska-Malec M, Łanoszka B, Chomik K, Gajek M, Michalik A, Nowicka E, Tarnawski R, Rutkowski T, Jarząb M. Kubeczko M, et al. Among authors: jarzab m. Cancers (Basel). 2023 Jan 22;15(3):690. doi: 10.3390/cancers15030690. Cancers (Basel). 2023. PMID: 36765648 Free PMC article.
Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors.
Wygoda Z, Kula D, Bierzyńska-Macyszyn G, Larysz D, Jarzab M, Właszczuk P, Bazowski P, Wojtacha M, Rudnik A, Stepień T, Kaspera W, Etmańska A, Składowski K, Tarnawski R, Kokocińska D, Jarzab B. Wygoda Z, et al. Among authors: jarzab b, jarzab m. Hybridoma (Larchmt). 2006 Jun;25(3):125-32. doi: 10.1089/hyb.2006.25.125. Hybridoma (Larchmt). 2006. PMID: 16796458 Clinical Trial.
122 results